HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Old agent, new experience: colistin use in the paediatric Intensive Care Unit--a multicentre study.

Abstract
Nosocomial infections caused by multidrug-resistant (MDR) microorganisms are a common problem around the world, especially in Intensive Care Units. The aim of this study was to investigate the efficacy and safety of colistin therapy in paediatric patients with severe nosocomial infections caused by MDR Gram-negative bacteria. There were 87 episodes in 79 paediatric Intensive Care Unit patients in five different hospitals; each patient was treated intravenously with colistin and evaluated. Of the 79 patients, 54.4% were male and the median age was 30 months. The most commonly isolated microorganism was Acinetobacter baumannii, the most common isolation site was tracheal aspirate fluid and the most common type of infection was ventilator-associated pneumonia. The mean colistin dose in patients without renal failure was 5.4 ± 0.6 mg/kg/day, the mean therapy duration was 17.2 ± 8.4 days and the favourable outcome rate was 83.9%. Serious side effects were seen in four patient episodes (4.6%) during therapy; two patients suffered renal failure and the others had convulsive seizures. Other patients tolerated the drug well. The infection-related mortality rate was 11.5% and the probability of death within the first 9 days of treatment was 10 times higher than after the first 9 days. In conclusion, this study suggests that colistin is effective in the treatment of severe nosocomial infections caused by MDR Gram-negative bacteria and is generally well tolerated by patients, even after relatively long-term use.
AuthorsMuhammet Sukru Paksu, Sule Paksu, Adil Karadag, Gülnar Sensoy, Nazik Asilioglu, Dincer Yildizdas, Basak Nur Akyildiz, Tanil Kendirli, Demet Demirkol, Muhammet Akgun, Emine Alp, Ergin Ciftci, Akif Koray Guney, Naci Murat
JournalInternational journal of antimicrobial agents (Int J Antimicrob Agents) Vol. 40 Issue 2 Pg. 140-4 (Aug 2012) ISSN: 1872-7913 [Electronic] Netherlands
PMID22727770 (Publication Type: Journal Article, Multicenter Study)
CopyrightCopyright © 2012 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.
Chemical References
  • Colistin
Topics
  • Acinetobacter Infections (drug therapy, microbiology)
  • Acinetobacter baumannii (isolation & purification, pathogenicity)
  • Adolescent
  • Child
  • Child, Preschool
  • Colistin (administration & dosage, adverse effects, therapeutic use)
  • Cross Infection (drug therapy, microbiology)
  • Drug Administration Schedule
  • Drug Evaluation (methods)
  • Drug Resistance, Multiple, Bacterial
  • Female
  • Humans
  • Infant
  • Intensive Care Units, Pediatric
  • Male
  • Pseudomonas Infections (drug therapy, microbiology)
  • Pseudomonas aeruginosa (isolation & purification, pathogenicity)
  • Renal Insufficiency (chemically induced)
  • Retrospective Studies
  • Seizures (chemically induced)
  • Time Factors
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: